Partner With a Trusted Clinical Trials Site in Sydney
Key Health Clinical Research Unit has successfully partnered with Australian and international sponsors, delivering reliable performance and patient-focused research outcomes.
We welcome discussions regarding upcoming clinical trials, feasibility assessments, and research partnerships in Australia.
Welcome to Key Health Clinical Research Unit
Key Health Clinical Research Unit is a leading clinical trials site in Sydney, Australia, operating within a well-established network of general practice clinics. Our integrated model provides access to a diverse and reliable patient population, supporting efficient and consistent recruitment across multiple therapeutic areas.
Based in Sydney, NSW, we collaborate with local and international sponsors, CROs, and research partners, offering a responsive, experienced, and compliant research environment.
Our network supports recruitment across a broad demographic, including paediatric, adult, elderly, and immunocompromised populations, ensuring inclusive and representative study participation.
Our Clinical Trial Capabilities
Key Health’s Clinical Research Unit is headquartered in Sydney CBD, with active clinical trial operations across multiple locations, including Pagewood and Bondi Junction. We have the capability to deliver Phase I, II, and III clinical trials across all Key Health clinics, enabling flexible, scalable study delivery throughout Sydney.
Operating within a primary care (GP) setting, our network sees hundreds of patients daily, providing access to a diverse and engaged participant database for strong patient recruitment and efficient trial execution. Our purpose-built clinical trial facilities support high-quality data collection, strict participant safety, and compliant study delivery.
We operate in accordance with ICH-GCP (Good Clinical Practice), NHMRC National Statement, and TGA regulations in Australia.
With established infrastructure, experienced medical teams, and multi-site capability, Key Health is well-positioned to deliver high-quality clinical research across a wide range of therapeutic areas.
Key Health Clinical Research Unit provides end-to-end clinical trial services in Sydney, Australia, supporting sponsors across multiple therapeutic areas within a primary care (GP) setting.
Our services include clinical trial management from study start-up and feasibility through to budgeting, scheduling, monitoring, and close-out. We also manage regulatory and ethics processes, including CTN submissions, HREC approvals, governance documentation, and protocol amendments in line with Australian requirements.
We enable fast and reliable patient recruitment in Sydney through our established GP clinic network, supported by robust data and quality management systems (CTMS and EDC) for accurate reporting, SAE management, and audit readiness. Our team also provides feasibility and site selection support, delivering realistic recruitment projections and experienced investigator engagement.
We conduct clinical trials across key therapeutic areas, including chronic disease, infectious diseases, women’s health, and neurology, with the capability to support both single-site and multi-site clinical trials across Australia.
Clinical Trial Services & Therapeutic Areas
Commitment to Quality & Compliance
Quality, safety, and ethical conduct are central to our operations. Our research unit is supported by experienced investigators and clinical research coordinators with strong regulatory and operational expertise.
We maintain:
Comprehensive Standard Operating Procedures (SOPs)
Ongoing GCP training for all research staff
Robust risk management and CAPA processes
Continuous quality improvement and audit readiness
Let’s Work Together
Contact Key Health Clinical Research Unit
📍 Key Health Clinical Research Unit (Key CRU)
281 Elizabeth Street, Sydney NSW 2000
📧 clinical.trials@keyhealth.com.au
📞 0473 404 917
Meet the team
-
Dr Anthony Yap
Co Founder Key Health
Dr Anthony Yap is a General Practitioner with over 25 years of clinical experience and more than 20 years’ involvement in clinical research, including early Phase I trials. He is the co-founder of Key Health Medical Centres, a GP-led network across Sydney with integrated clinical trials capability.Dr Yap has extensive experience as a Principal Investigator across multi-site trials, with a strong focus on metabolic disease, endocrinology, vaccines, and primary care–driven recruitment. His background in high-volume general practice enables rapid patient identification and enrolment, supported by structured data mining and in-consult recruitment pathways.
-
Dr Naheed Kanji
Co Founder Key Health
Dr Naheed Kanji is a highly experienced General Practitioner and co-founder of Key Health Medical Centres, with extensive experience in both clinical medicine and clinical trials delivery.
Dr Kanji has acted as Principal Investigator and Sub-Investigator across a range of Phase II trials, with particular strengths in women’s health, chronic disease, and preventive medicine. She is known for her patient-centred approach, supporting high retention rates and strong protocol adherence.
-
Dr Aaron Wong
Doctor/Pharmacist
Dr Aaron Wong is a General Practitioner and former pharmacist, bringing a strong foundation in pharmacology and evidence-based medicine to clinical research.He has experience as both a Principal Investigator and Sub-Investigator across multiple trials, contributing to study oversight, patient recruitment, and ongoing participant management. His dual background supports accurate medication management, protocol compliance, and high-quality data collection.
-
Dr. Stephanie Rufo
Clinical Trials Manager
Dr Stephanie Rufo has a strong research background, with a PhD in Biological Sciences, experience on site, and at Sponsor and CRO level. She manages the Key Health Clinical Research Unit and is responsible for study execution from start-up, through enrolment, follow-up and final close out. Stephanie has been in the clinical trial space for 10+ years with a keen interest in early phase trials. She is data oriented and science-focussed with a passion for delivering high quality research.
-
Alice Hawkes
Senior Clinical Trials Coordinator
Alice is a registered nurse with a Postgraduate Certificate in Nursing Leadership and Management, bringing over 10 years of clinical experience and 4 years of clinical research experience across multiple clinical trials. She has worked across diverse healthcare settings in both the UK and Australia, developing strong capabilities in stakeholder engagement and multidisciplinary collaboration. Alice is highly committed to patient safety, with a strong passion for service improvement and the delivery of high‑quality, patient‑centred care. -
Feiyun Lu (Astra)
Clinical Trials Nurse
Feiyun is a Registered Nurse and Clinical Research Nurse with a strong clinical foundation and a dedicated focus on clinical research.She has experience in patient care, clinical trial coordination, and protocol adherence. She supports the delivery of high-quality, patient-centred trials through meticulous coordination and care.
Facilities & Equipment
-
![Key Health Reception]()
01
Multiple Sites Across Sydney
-
![A healthcare worker administering a vaccination to a woman in a medical setting.]()
02
Vaccine refrigerators
-20 and -80 Freezers -
![GP consultation and patient care discussion at a medical clinic in Sydney]()
03
Real Time CTMS to streamline workflow – allowing study monitors to do remote monitoring visits
-
![Medical pathology and diagnostic testing services in a clinical laboratory]()
04
IP temperature-controlled storage
-
![Laboratory blood testing and sample processing for medical diagnostics]()
05
Centrifuge and lab processing facilities
-
![“Healthcare inventory and medical supply management in a clinical setting]()
06
Archiving facilities
Sponsor: DiaSorin Molecular
Respiratory Clinical Trial
To establish the accuracy of a Flu A/B, RSV and COVID-19 assay
Previous Studies conducted by Key Health CRU
Sponsor: Wintermute
Shingles Clinical Trial
A Phase 1b trial to assess the IP Solexan at alleviating pain and accelerating the healing process in patients suffering from shingles.
Sponsor: Novavax
Vaccine Clinical Trial
A Phase 3 study of the safety and immunogenicity of a COVID-19 Influenza
Combination Nanoparticle Vaccine and a Standalone Trivalent Nanoparticle
Influenza Hemagglutinin VaccineA Phase 1b trial to assess the IP Solexan at alleviating pain and accelerating the healing process in patients suffering from shingles.
Sponsor: Avecho
Sleep Insomnia Clinical Trial
A Phase 3 study evaluating the efficacy and safety of CBD TPM capsules in adults for use is the reduction of insomnia severity.